Fundz

F1 Oncology Changes Name To EXUMA Biotech; Announces New Round Of Financing To Advance Cellular Therapies

PRIVATEMar 12, 2020

Round Type

Funding Round

West Palm BeachBiotechnology

Description

 EXUMA Biotech Corp. (formerly F1 Oncology), a clinical-stage biotechnology company discovering and developing CAR-T therapies for solid and liquid tumors, today announced a $19M Series B round of financing that includes new investments by MSD Partners and F1 BioVentures, as well as conversion of notes held by individual investors. 

Quick answer

EXUMA Biotech Corp. raised an undisclosed amount in a Funding Round round, dated March 12, 2020. EXUMA Biotech Corp. is based in West Palm Beach, Florida, United States.

How much did EXUMA Biotech Corp. raise?
EXUMA Biotech Corp. raised an undisclosed amount in a Funding Round round on March 12, 2020.
What does EXUMA Biotech Corp. do?
EXUMA Biotech Corp is a private Delaware corporation formed in November 2015 with operations in West Palm Beach, Florida and international affiliates in the Cayman Islands and Shanghai, China.
Where is EXUMA Biotech Corp. based and how big is it?
EXUMA Biotech Corp. is based in West Palm Beach, Florida, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as EXUMA Biotech Corp. that raised within 45 days of this round, from Fundz verified event records.

  • Checkmate Pharmaceuticals, Inc. raised $10M on April 24, 2020.
  • Harvard Apparatus Regenerative Technology raised $2.2M on April 23, 2020.
  • Accent Therapeutics raised $63M (Series B) on April 23, 2020.
  • Cytovale raised an undisclosed amount (Funding Round) on April 23, 2020.
  • Atai Life Sciences N.V raised $24M (Convertible Note) on April 23, 2020.
  • Gibson Oncology raised $3.8M (Seed) on April 23, 2020.

Who to call at EXUMA Biotech Corp., and when

A new round usually means EXUMA Biotech Corp. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day EXUMA Biotech Corp. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at EXUMA Biotech Corp., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at EXUMA Biotech Corp.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

EXUMA Biotech Corp.

Location

625 North Flagler Drive

West Palm Beach, Florida, United States

About

EXUMA Biotech Corp is a private Delaware corporation formed in November 2015 with operations in West Palm Beach, Florida and international affiliates in the Cayman Islands and Shanghai, China. EXUMA leverages its globally integrated science, development and informatics teams located across multiple time zones to accelerate the design, high-throughput screening, discovery and development of Chimeric Antigen Receptor T cell (CAR-T) candidates for both solid and liquid tumor malignancies. The company is developing logic gated CAR-T platforms to advance TME-restricted cellular therapies for solid tumors, platforms that will allow for same-day, rapid point of care (rPOC) administration for solid or liquid tumors, and highly scalable systems for global therapy deployment, beginning in Asia. Learn more at exumabio.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment EXUMA Biotech Corp. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for EXUMA Biotech Corp.'s next move

See what Strategic adds

EXUMA Biotech Corp. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.